Recombinant Mouse IL-22 protein (His Tag)

Species

Mouse

Purity

>95 %, SDS-PAGE

Tag

His Tag

Activity

EC50: 2-8 ng/mL

Cat no : Eg0405



Product Information

Purity >95 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Measured by its ability to induce IL-10 secretion in COLO 205 human colorectal adenocarcinoma cells. The ED50 for this effect is 2-8 ng/mL.
Expression HEK293-derived Mouse IL-22 protein Leu34-Val179 (Accession# Q9JJY9) with a His tag at the C-terminus.
GeneID 50929
Accession Q9JJY9
PredictedSize 20.4 kDa
SDS-PAGE 26-38 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Interleukin-22 (IL-22) is a recently described IL-10 family cytokine that is produced by T helper (Th) 17 cells, γδ T cells, NKT cells, and newly described innate lymphoid cells (ILCs). IL-22 has the potential to interact with IL-10 because it binds to the IL-10R2c chain with IL-22R1 in its receptor complex. Binding can be blocked by the soluble receptor, IL-22 binding protein (IL-22BP). IL-22 primarily targets nonhematopoietic epithelial and stromal cells, where it can promote proliferation and play a role in tissue regeneration. IL-22 can contribute to immune disease through the stimulation of inflammatory responses, S100s and defensins. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10.

References:

1. Pestka S. et al. (2004) Annu Rev Immunol. 22: 929-79. 2. Wolk K. et al. (2002) J Immunol. 168(11): 5397-5402. 3. Zheng Y et al. (2007) Nature. 445: 648-651. 4. Zheng Y et al. (2008) Nat Med. 14: 282-289. 5. Xie MH, et al. (2000) J Biol Chem. 275: 31335-9. 6. Jones BC, et al. (2008) Structure. 16:1333-44.